On one hand, exenatide is a prototypical GLP-1RA known for its potent effects on weight reduction and lowering LFC, instilling confidence in its use for MASLD
4.4 Challenges and future directions Ferroptosis diagnosis still faces a number of difficulties despite tremendous advancements
Important safety considerations include a boxed warning for medullary thyroid carcinoma risk, monitoring for pancreatitis (severe abdominal pain), gallbladder disease, and potential hypoglycemia when used with insulin or sulfonylureas
Future studies may evaluate Retatrutide for liver conditions, but currently Survodutide has the stronger evidence base for MASH treatment
Similar content being viewed by others Introduction Cardiovascular disease (CVD) remains the leading cause of death in the USA, accounting for 928,741 deaths in the year 2024